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The base excision repair pathway plays an important role in correcting
damage induced by either physiological or external effects. This repair
pathway removes incorrect bases from the DNA. The uracil base is among
the most frequently occurring erroneous bases in DNA, and is cut out
from the phosphodiester backbone via the catalytic action of uracil-DNA
glycosylase. Uracil excision repair is an evolutionarily highly conserved
pathway and can be specifically inhibited by a protein inhibitor of uracil-
DNA glycosylase. Interestingly, both uracil-DNA glycosylase (Staphylococ-
cus aureus uracil-DNA glycosylase; SAUDG) and its inhibitor (S. aureus
uracil-DNA glycosylase inhibitor; SAUGI) are present in the staphylococ-
cal cell. The interaction of these two proteins effectively decreases the effi-
ciency of uracil-DNA excision repair. The physiological relevance of this
complexation has not yet been addressed in detailed; however, numerous
mutations have been identified within SAUGI. Here, we investigated
whether these mutations drastically perturb the interaction with SAUDG.
To perform quantitative analysis of the macromolecular interactions, we
applied native mass spectrometry and demonstrated that this is a highly
efficient and specific method for determination of dissociation constants.
Our results indicate that several naturally occurring mutations of SAUGI
do indeed lead to appreciable changes in the dissociation constants for
complex formation. However, all of these Kd values remain in the nanomo-
lar range and therefore the association of these two proteins is preserved.
We conclude that complexation is most likely preserved even with the natu-
rally occurring mutant uracil-DNA glycosylase inhibitor proteins.
The preservation of genome integrity is of key impor-
tance for cell viability and faithful transmission of
genetic information to subsequent generations. Various
damage repair pathways are responsible for efficient
and potentially error-free correction of DNA damage.
Among repair pathways, the base excision repair acts to
remove base errors due to different chemical reactions,
such as oxidation, alkylation and deamination [1,2].
Abbreviations
AP, apurinic/apyrimidinic; SAUDG, Staphylococcus aureus uracil-DNA glycosylase; SAUGI, Staphylococcus aureus uracil-DNA glycosylase
inhibitor; UDG, uracil-DNA glycosylase; UGI, uracil-DNA glycosylase inhibitor.
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Base excision repair is initiated by a DNA N-glyco-
sylase enzyme, which is strictly specific for a given
modified DNA base. Glycosylase binds to the erro-
neous base and removes it from DNA, leaving apuri-
nic/apyrimidinic (AP) sites. In the next step, the AP
sites are cleaved by AP endonuclease. The repair path-
way can follow either a short patch or a long patch
route leading towards reconstruction of the original
error-free DNA status [3].
Among the erroneous bases, uracil occurs with a
high frequency [4]. Uracil may result from the incorpo-
ration of dUTP during replication, creating a U:A pair,
or the spontaneous deamination of cytosine, creating a
premutagenic U:G mispair [5]. A recent study indicated
that low levels of uracils in genomic DNA of several
human cell lines may accumulate in the centromeric
regions of chromosomes, although the physiological
significance of this finding is yet to be discovered [6].
The clearance of dUTP from the cellular pool is there-
fore of high importance to prevent DNA uracilation.
dUTPase enzymes fulfill this role in a highly efficient
manner due to their utmost specificity for dUTP paired
with a considerable catalytic rate constant [5,7,8]. If,
however, uracil still gets incorporated into DNA or
appears from cytosine deamination, another repair
enzyme can correct the uracil mistake. Several families
of uracil-DNA glycosylase (UDG) have evolved to cut
out uracil from DNA [4,9,10]. The catalytically most
active UDG isoform (encoded by the ung gene) is usu-
ally present from bacteria to eukaryotes; however,
some eukaryote genomes lack the ung gene. Based on
mutational studies, it is well established that UDG defi-
ciency leads to increased mutational rates [11].
Several inhibitory proteins can modulate catalytic
activity of the UDG enzyme. At present, three differ-
ent uracil-DNA glycosylase inhibitor proteins have
been described in the literature, namely Uracil-DNA
glycosylase inhibitor (UGI) [12,13], p56 [14–16] and
Staphylococcus aureus UGI (SAUGI) [17–19]. The
amino acid sequences of these inhibitory proteins are
strikingly different; however, all of them present a pro-
tein surface mimicking the DNA negatively charged
double helical structure [20,21].
UGI is produced by Bacillus subtilis PBS1 and PBS2
bacteriophages containing uracil instead of thymine in
their genome. The bacteriophages apply UGI to protect
their DNA from host cell UDG [12]. p56 is produced by
B. subtilis phi29 phage. Unlike PBS1 and PBS2, this
phage does not contain uracil in the genome; however,
it has been demonstrated that p56 presents considerable
protection for viral DNA replication [14].
The third UGI protein, SAUGI, is encoded by Sta-
phylococcus aureus [21]. It has been proposed that the
gene encoding SAUGI is located in mobile genetic ele-
ments of the S. aureus genome [22]. Different strains
of S. aureus encode numerous mutated versions of
SAUGI [18]. While the exact biological role of SAUGI
is still unclear, it is highly interesting to note that
S. aureus also encodes an inhibitory protein for dUT-
Pase, namely Stl [23–27].
It is therefore apparent that S. aureus possesses a
complex system for uracil-DNA metabolism, as
detailed in Fig. 1. Both repair enzymes acting against
uracil in DNA, dUTPase and UDG, as well as their
protein inhibitors, Stl and SAUGI, can be present in
the staphylococcal cell, creating intertwined regulatory
pathways. It is still unclear how this regulatory poten-
tial may be exploited.
In the present work, we focused on characterization of
the interaction between Staphylococcus aureus UDG
(SAUDG) and SAUGI, using mass spectrometry as a
sophisticated state-of-the art method. Our aim was to
investigate whether naturally occurring mutations within
the SAUGI sequence may have major consequences for
complex formation. We therefore constructed several
mutant SAUGI proteins and analyzed their binding to
SAUDG exploiting native mass spectrometry.
Materials and methods
In silico Blast search and alignments
For homologous sequences of SAUGI proteins, the NCBI
Blast search was performed using the wild-type SAUGI
sequence (Uniprot code: Q936H5). The search was per-
formed using translated nucleotide query (blastx), and the
protein sequences database was non-redundant, in the S. au-
reus (taxid 1280) organism. The alignment sequences similar-
ity was higher than 90%, which was adjusted manually.
Cloning and mutagenesis
SAUDG and SAUGI vectors were from H.-C. Wang (Tai-
pei Medical University) [17]. A His6 tag was inserted into
the SAUGI encoding vector.
The SAUGI mutant constructs were engineered by site-
directed mutagenesis using the QuickChange method (Agi-
lent, Santa Clara, CA, USA). Primers used for mutagenesis
(Table 1) were synthesized by (Eurofins Genomics GmbH,
Ebersberg, Germany). Constructs were verified by DNA
sequencing at Eurofins MWG GmbH.
SAUGI and SAUDG protein expression and
purification
Protein expression and purification were performed as
described previously [19]. In brief, expression was
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performed in E. coli Rosetta BL21 (DE3) PlysS cells
(Novagen, EMD Biosciences, Inc., Merck KGaA, Darm-
stadt, Germany) at 16 °C. Cells were harvested by centrifu-
gation (4 °C, 4000 g, 20 min), and extracted by sonication.
Cell supernatants were used for purification of the proteins
on an Ni-NTA column. Elution of SAUDG, SAUGIWT
and mutant SAUGI constructs was done using elution
buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
2 mM KH2PO4, pH 7.5).
Mass spectrometry
Mass spectrometry measurement was performed on a
(Waters, International Equipment Trading Ltd, Mundelein,
IL, USA) Q-Tof Premier mass spectrometer equipped with
an electrospray source. The instrument parameters were set
up as follows: electrospray ionization capillary voltage
2.8 kV, source temperature 90 °C, desolvation temperature
160 °C, cone gas flow 25 Lh1, desolvation gas flow
600 Lh1, cone voltage 60 V, extraction cone 5.0 V, ion
guide 3.5 V, ion guide gas flow 10 mLmin1. Samples were
introduced by direct injection with a flow rate of
10 lLmin1. Mass spectra were obtained under native con-
ditions in the 800–7000 m/z range; the ions were generated
from aqueous 50 mM NH4HCO3 buffer solution (pH 7.8)
containing the protein at 2 lM SAUDG and 0.5–2 lM
SAUGI concentration.
Data analysis
To determine the dissociation constant, each sample was
mixed from the same SAUDG stock solution. For each
Table 1. Primers for constructing E24H, H87E, D59Y, M89K and I50T point mutations.
SAUGIE24H F-Primer 50 – cctaccaaaggatgaaaagtggcattgtgaatctatcgaggaaatcg – 30
R-Primer 50 – cgatttcctcgatagattcacaatgccacttttcatcctttggtagg – 30
SAUGIH87N F-Primer 50 – tcggctatatcgatgaaaataacgatatggatttcttatacctacac – 30
R-Primer 50 – gtgtaggtataagaaatccatatcgttattttcatcgatatagccga – 30
SAUGID59Y F-Primer 50 – cctatacctactactcttatacacttcacgaaag – 30
R-Primer 50 – ctttcgtgaagtgtataagagtagtaggtatagg – 30
SAUGIM89K F-Primer 50 – cgatgaaaatcacgataaggatttcttatacctac – 30
R-Primer 50 – gtaggtataagaaatccttatcgtgattttcatcg – 30
SAUGII50T F-Primer 50 – ggggcactcagtaataaaacacttcaaacctatacctac – 30
R-Primer 50 – gtaggtataggtttgaagtgttttattactgagtgcccc – 30
The bases, coding the altered amino acids are highlighted in bold letters.
Fig. 1. Model of pathways and protein
factors collaborating in DNA maintenance.
The scheme shows the role of the two
main protein enzymes, UDG and dUTPase,
in keeping uracil out of DNA. Inhibitor
proteins against UDG (UGI, SAUGI and
p56, acting in different organisms) and
dUTPase (Stl) are also marked on the
scheme.
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inhibitor protein tested, seven SAUDG/inhibitor ratios
were measured, while keeping the SAUDG concentration
2 lM. The measured data were analyzed by summing all
spectra during the 5 min measurement and taking into
account the three most intense peaks belonging to the
SAUDG protein and three to the complex. After calculat-
ing the ratio of the protein complex peak area to the
SAUDG peak area, we used a modified formula from
Daniel et al. [28] to fit the data. Formula parameters were























where I(P*L) and I (P) are the measured signals for the
complex and the free SAUDG, respectively. [P]0 and [L]0
are the initial protein concentrations and K is the associa-
tion constant. The dissociation constant can be calculated
as 1/K. As demonstrated previously, the microchannel plate
detector has three to five times lower signal for a two times
increase in mass, depending on instrument parameters, and
therefore a constant, c, was introduced.
Results and Discussion
Our aim was to apply native mass spectrometry to
determine dissociation constants characterizing the
interaction between SAUDG and naturally occurring
mutant variants of SAUGI. It has been already recog-
nized that native mass spectrometry is a relevant and
suitable technique to investigate proteins in their
native conformation [26,29]. However, data character-
izing dissociation constants of macromolecular com-
plexes obtained by mass spectrometry are still rare in
the literature [30].
In order to select putatively relevant mutant variants
of SAUGI, we performed sequence alignments of all
SAUGI sequences present in public databases (27
sequences). Since the physiological function of
SAUGI, to our current knowledge, is inhibition of
SAUDG, we focused on those peptide segments pre-
sent in the SAUGI protein that are known to be
involved in complex formation with SAUDG (the
three-dimensional structure of the SAUGI–SAUDG
complex has been published: PDB ID 3WDG) [17].
Figure 2 presents the SAUGI sequences wherein we
have indicated the peptide segments involved in the
complex formation. In addition, residues where mutant
variants were selected for further study are highlighted.
Figure 2 also shows the position of the selected resi-
dues within the three-dimensional structure of the
complex. The rationale for selecting individual mutant
variants considered the change in the character of the
residue upon mutation: those mutations were consid-
ered where major variation occurred in hydrophobicity
or charged/polar character.
We have measured the complex formation of
SAUDG and five naturally occurring mutants (SAU-
GIE24H, SAUGII50T, SAUGID59Y, SAUGIH87N,
Fig. 2. Structural representation of
SAUDG:SAUGI complexes (visualized with
PYMOL Graphics System, DeLano Scientific,
San Carlos, CA, USA). Three-dimensional
structural model of the complex formed by
SAUDG (green cartoon) and SAUGI
(yellow cartoon) (PDB: 3WDG). Residues
within the SAUGI protein, selected for
further study are depicted in stick model
with purple carbons and atomic coloring.
Bottom panel presents the amino acid
sequence of SAUGI. In the sequence,
amino acids participating in the formation
of the SAUDG:SAUGI complex surface are
underlined, and positions selected for
further study are highlighted in purple.
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SAIUGIM89K) using mass spectrometry. Preliminary
experiments indicated that the 0.5–2 lM concentration
range for the protein complex result is optimal to
obtain well-characterized spectrum signals. Figure 3
shows a representative mass spectrum of the SAUDG:
SAUGIE24H complex.
In the spectrum, peaks assigned to SAUDG and the
protein complex are marked. No peaks associated with
free SAUGIE24H can be observed. The ratio of the
complex and free SAUDG signals is a relevant mea-
sure of the complex formation. As described in Materi-
als and methods, the dissociation constant was
calculated based on this ratio, determined using several
measurements with different concentrations of the
SAUGI protein, while the concentration of SAUDG
was kept constant. Figure 4 presents the complex to
free protein ratio as a function of the SAUGIE24H con-
centration. For the other mutants, the titration curves
can be found in the Supporting information (Fig. S1).
The dissociation constants obtained for the com-
plexes of SAUDG with wild-type and mutant SAUGI
constructs are listed in Table 2. We note that among
the different mutant variants, one SAUGI construct
possesses a somewhat stronger interaction with
SAUDG, while the other mutations either weaken the
interaction or do not perturb it.
Previously the complex formation between wild-type
SAUGI and the SAUGIE24H mutant has been partially
investigated by microscale thermophoresis and isother-
mal titration microcalorimetry [19]. With regard to the
dissociation constant determined for the SAUDG:
SAUGIWT complex, it is of interest to note that our
currently determined value obtained by mass spec-
trometry (14.4  1.5 nM) compares more favorably to
the dissociation constant of the same complex deter-
mined by surface plasmon resonance (1.2 nM) [17], as
compared with the data obtained by isothermal titra-
tion microcalorimetry (131  31 nM) [19]. It has been
already observed that the lengthy microcalorimetry
technique is not optimal for proteins that are sensitive
to stirring, temperature and buffer/salt conditions.
Since a microcalorimetry titration takes about 2 h to
be completed, it can be used only for proteins that can
Fig. 3. Mass spectrometric analysis of the protein complex, where the concentration of SAUDG and SAUGIE24H was 2 and 1.25 lM,
respectively.
Fig. 4. Determination of the dissociation constant of the SAUDG:
SAUGIE24H complex. Data are plotted according to Materials and
methods. The fitted curve (red line) is also shown.
424 FEBS Open Bio 9 (2019) 420–427 ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Specific variations in SAUDG and SAUGI V. Papp-Kadar et al.
withstand these conditions without significant confor-
mation changes. Both SAUDG and SAUGI proteins
showed a tendency to precipitate in the microcalorime-
ter. The surface plasmon resonance technique also pre-
sented significant difficulties in the determination of the
dissociation phase, due to the exceptionally strong com-
plexation between SAUDG and SAUGI. Considering
these difficulties, a different approach was sought, and
mass spectrometry proved to be applicable.
As shown in Table 2, we have observed that among
the investigated SAUGI mutants there is one in which
the strength of complex formation is highly increased.
In this specific case (E24H mutation), a glutamic acid
residue has been replaced by a histidine. In the com-
plex structure of SAUDG:SAUGI, this glutamic acid
residue does not participate in any strong interaction
(cf. distances shown on Fig. 5, respective panel). How-
ever, the histidine residue in the mutant variant may
form polar contact with a glutamine residue (Q66) of
SAUDG.
In three further mutations, the dissociation constant
is considerably increased (SAUGIH87N, SAUGID59Y
and SAUGIM89K). In all these cases, inspection of the
three-dimensional structure provides relevant consider-
ations, in agreement with the weakening of the com-
plexation (Fig. 5). For the SAUGIH87N mutant, it is
Table 2. Dissociation constants of SAUGI E24H, H87E, D59Y,
M89K and I50T mutations.
Kd (nM)
SAUGIWT 14.4  1.5
SAUGIE24H 1.7  1.4
SAUGIH87N 69.4  5.5
SAUGID59Y 96.3  8.0
SAUGIM89K 38.3  1.0
SAUGII50T 14.1  0.2
Fig. 5. Three-dimensional structural model of the complex formed by SAUDG (green cartoon) and SAUGI (yellow cartoon) (PDB: 3WDG).
Shown are the proposed conformation of several mutated residues of SAUGI (SAUGIE24H, SAUGID59Y, SAUGIH87N, SAIUGIM89K and
SAUGII50T) at the SAUDG: SAUGI interaction surface. Residues involved in interactions with the selected SAUGI mutations are shown in
stick model, colored according to atomic coloring (carbons are in yellow for the wild-type and in light gray for the mutants). Only the most
probable mutant amino acid conformer generated by the PYMOL Mutagenesis tool is depicted. Dashed lines with numbers indicate atomic
distances inangstr€oms.
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well observable that the histidine residue in the wild-
type SAUGI participates in the aromatic interaction
with tyrosine 187 (Y187) of SAUDG. The asparagine
mutation fails to perform this interaction, hence weak-
ening complex formation.
Considering the SAUGID59Y mutant, it is to be
noted that in the wild-type SAUGI, the aspartic acid
residue 59 (D59) forms a charged interaction with the
amino group of lysine 79 (K79) of SAUDG. This
strong charged interaction is lost when aspartate 59 is
mutated to tyrosine.
For another mutant (SAUGIM89K), a methionine
residue in the wild-type SAUGI is accommodated in a
hydrophobic pocket of SAUDG. Substitution of this
methionine for a charged lysine residue interferes with
this interaction thereby weakening complex formation.
Finally, the SAUGII50T mutant exhibits a similar Kd
to wild-type SAUGI. This is in good agreement with the
fact that the isoleucine residue in the wild-type protein
does not participate in any strong interactions with
SAUDG.
In conclusion, our experimental data indicate that
several naturally occurring mutant variants of SAUGI
still allow considerably strong complex formation with
SAUDG. Even in the strongest perturbation (observed
for the SAUGID59Y variant), the dissociation constant
with SAUDG is rather low in the submicromolar range.
We propose that under physiological conditions, the
observed subtle variations of the strength of complexa-
tion between SAUDG and the SAUGI variants may not
have strongly disturbing effects. Our data therefore
argue that complexation between SAUGI and SAUDG
is evolutionarily conserved and only those mutant vari-
ants of SAUGI are preserved that still constitute a rele-
vant interaction network with SAUDG.
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Fig. S1. Determination of the dissociation constant of
the SAUDG:SAUGI variant complexes, according to
Materials and methods. The obtained data set (black
points), and the fitted curve (red line) are shown in the
case of SAUGIWT (A), SAUGII50T (B), SAUGID59Y
(C), SAUGIH87N (D), and SAIUGIM89K (E).
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